60 participants
Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-04
- Start Date:
- 2026-03-02
- Completion:
- 2027-02-14
Conditions
- Small Cell Lung Cancer (SCLC)
- Relapsed/Refractory SCLC
- Extensive-stage SCLC
Interventions
- BIOLOGICAL
- DRUG
No Results Yet